(688276)"Changchun Bcht Biotechnology Co."Announcement on Convening the Q3 2026 Performance Briefing
Filed with SSE · Stock code 688276 · · 2 pages · Chinese
Summary by 6ix AI
Participants will include key executives such as the vice chairman and the general manager. Investors can submit questions in advance and will have the opportunity to engage during the session.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Changchun BCHT Biotechnology Co. on 6ix
Story so far
- Announcement on Voluntary Disclosure Regarding the Acceptance of the Clinical Trial Application for the Combination Formulation of Recombinant Human Anti-Respiratory Syncytial Virus (RSV) Monoclonal Antibody Injection
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Return of Previously Used Funds Raised for Temporary Working Capital Supplement and Use of a Portion of Idle Funds Raised for Temporary Working Capital Supplement
Earlier from Changchun BCHT Biotechnology
- Announcement on Voluntary Disclosure Regarding the Acceptance of the Clinical Trial Application for the Combination Formulation of Recombinant Human Anti-Respiratory Syncytial Virus (RSV) Monoclonal Antibody Injection
- Semi-annual Report for 2026
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Return of Previously Used Funds Raised for Temporary Working Capital Supplement and Use of a Portion of Idle Funds Raised for Temporary Working Capital Supplement
- Announcement on Resolutions of the 2025 Annual General Meeting
Later from Changchun BCHT Biotechnology
- (688276)"Changchun Bcht Biotechnology Co."Announcement on Merger by Absorption of the Wholly-owned Subsidiary Jilin Huikang Biopharmaceutical Co., Ltd.
- (688276)"Changchun Bcht Biotechnology Co."Announcement on Notifying Creditors of Merger by Absorption of Wholly-owned Subsidiary
- (688276)"Changchun Bcht Biotechnology Co."Announcement on Provision for Asset Impairment for the First Three Quarters of 2026
- (688276)"Changchun Bcht Biotechnology Co."Report for Q3 2026
Follow Changchun BCHT Biotechnology into a list and get an email when it puts out news.
Follow Changchun BCHT Biotechnology